Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, par value, $0.001 per share
-
Shares outstanding
-
50,013,453
-
Total 13F shares
-
12,450,799
-
Share change
-
-1,955,581
-
Total reported value
-
$9,437,810
-
Price per share
-
$0.76
-
Number of holders
-
37
-
Value change
-
-$1,624,435
-
Number of buys
-
17
-
Number of sells
-
14
Institutional Holders of NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) as of Q4 2025
As of 31 Dec 2025,
NEUROONE MEDICAL TECHNOLOGIES Corp - Common Stock, par value, $0.001 per share (NMTC) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,450,799 shares.
The largest 10 holders included
Bleichroeder LP, BARD ASSOCIATES INC, VANGUARD GROUP INC, PERKINS CAPITAL MANAGEMENT INC, Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ESSEX INVESTMENT MANAGEMENT CO LLC, Cambridge Investment Research Advisors, Inc., and NORTHERN TRUST CORP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.